Open AccessBeneficial effects of posttransplant dipeptidyl peptidase-4 inhibitor administration after pancreas transplantation to improve β cell function
Author(s) -
Hye-Won Jang,
Chang Hee Jung,
Youngmin Ko,
Seong Jun Lim,
Hye Eun Kwon,
Joohee Jung,
Hyuksool Kwon,
Young Hoon Kim,
Sung Shin
Publication year - 2021
Publication title -
annals of surgical treatment and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.559
H-Index - 25
eISSN - 2288-6796
pISSN - 2288-6575
DOI - 10.4174/astr.2021.101.3.187
Subject(s) - medicine , transplantation , gastroenterology , dipeptidyl peptidase , pancreas , dipeptidyl peptidase 4 , log rank test , pancreas transplantation , pharmacology , diabetes mellitus , endocrinology , survival analysis , type 2 diabetes , biology , enzyme , kidney transplantation , biochemistry
Dipeptidyl peptidase-4 (DPP-4) inhibitors lower blood glucose levels and enhance the function of pancreatic β cells. Yet, it is unknown whether posttransplant administration of DPP4 inhibitors is beneficial for pancreas transplant recipients.